MII IG Medikation
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: mii-exa-medikation-medication-caelyx

Raw json | Download

{
  "resourceType" : "Medication",
  "id" : "mii-exa-medikation-medication-caelyx",
  "meta" : {
    "profile" : [
      🔗 "https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/Medication|2027.0.0-ballot"
    ],
    "security" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code" : "HTEST",
        "display" : "test health data"
      }
    ]
  },
  "language" : "de",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Medication mii-exa-medikation-medication-caelyx</b></p><a name=\"de-mii-exa-medikation-medication-caelyx\"> </a><a name=\"de-hcmii-exa-medikation-medication-caelyx\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-medikation-medication.html\">MII PR Medikation Medication</a> version: 2027.0.0-ballot</p><p style=\"margin-bottom: 0px\">Security Label: <a href=\"http://terminology.hl7.org/7.3.0/CodeSystem-v3-ActReason.html\">test health data (Details: ActReason code HTEST = 'test health data')</a></p></div><p><b>code</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/ifa/pzn 17313306}, {http://fhir.de/CodeSystem/bfarm/atc L01DB01}\">Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1</span></p><p><b>status</b>: Active</p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 11213000}\">Concentrate for solution for infusion</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>IsActive</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fdasis.nlm.nih.gov 82F2G7BL4E}, {http://terminology.hl7.org/CodeSystem/CAS 25316-40-9}\">DOXORUBICIN HYDROCHLORIDE</span></td><td>true</td><td>50 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codemg = 'mg')</span>/25 ml<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codeml = 'ml')</span></td></tr></table></div>"
  },
  "code" : {
    "coding" : [
      {
        "system" : "http://fhir.de/CodeSystem/ifa/pzn",
        "code" : "17313306",
        "display" : "Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1"
      },
      {
        "system" : "http://fhir.de/CodeSystem/bfarm/atc",
        "version" : "2023",
        "code" : "L01DB01",
        "display" : "Doxorubicin"
      }
    ]
  },
  "status" : "active",
  "form" : {
    "coding" : [
      {
        "system" : "http://standardterms.edqm.eu",
        "code" : "11213000",
        "display" : "Concentrate for solution for infusion"
      }
    ]
  },
  "ingredient" : [
    {
      "itemCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://fdasis.nlm.nih.gov",
            "code" : "82F2G7BL4E",
            "display" : "DOXORUBICIN HYDROCHLORIDE"
          },
          {
            "system" : "http://terminology.hl7.org/CodeSystem/CAS",
            "code" : "25316-40-9"
          }
        ]
      },
      "isActive" : true,
      "strength" : {
        "numerator" : {
          "value" : 50,
          "unit" : "mg",
          "system" : "http://unitsofmeasure.org",
          "code" : "mg"
        },
        "denominator" : {
          "value" : 25,
          "unit" : "ml",
          "system" : "http://unitsofmeasure.org",
          "code" : "ml"
        }
      }
    }
  ]
}